New SPAC Filing: TKK Symphony Acquisition Corp. Files for $200 Million IPO
by Kristi Marvin on 2018-07-30 at 6:27pm

TKK Symphony Acquisition Corporation:  Focused on Consumer/Lifestyle in China

After the market close today, TKK Symphony Acquisition Corporation filed for a $200 million SPAC IPO with a focus on the Consumer and Lifestyle sectors in China. TKK Symphony is being led by Sing Wang, as Chairman and CEO.  Mr. Sing Wang is currently Chairman of TKK Capital, a private equity/wealth management company, and is also CEO and Director of CM Seven Star Acquisition Corporation.

Looking at this IPO’s structure, there is a new twist to the completion deadline extension.  Specifically, TKK is allowed no more than one 4-month extension on top of their stated 18 months. Plus, in order to access that extension, there is no shareholder vote. Instead, TKK must issue to shareholders, via a dividend, another warrant to purchase one-half of one share.  That means a potential extra 20,000,000 warrants (for 1/2 share) added to the cap table.  This essentially turns the deal into a “1 share + 1 full warrant + 1 full right” SPAC, rather than the initial 1+1/2+1. (Terms for the dividend warrant are the same as the public warrants included in the unit).

On the one hand, removing the vote protects the cash in trust (temporarily). On the other hand, now they’re back to a big (potential) warrant overhang. The potential dilution is certainly a big motivator to wrap things up by 18 months, but the biggest question I have is, how does having Sing Wang as a CEO of two SPACs work (CMSS and TKKS)?  The fact that Sing Wang is CEO of both SPACs is not that prominent in the filing.  Does this mean we can read through the lines and assume that very shortly this won’t be an issue anymore, i.e., CMSS will announce soon? Because frankly, this seems like a big conflict for a CEO. Which SPAC gets the best deal?

Keep in mind, this is the initial filing….a lot can happen between now and IPO.  However, for now, this is something that is worth keeping an eye on.

Listed below are the current deal terms and you can find the profile page for TKK Symphony here.

Summary of terms are as follows:
  • Focus:  Consumer/Lifestyle in China
  • $10.00 unit comprised of one Ordinary Share + one Warrant (1/2 share) + one Right
  • Each Right entitles the holder to receive one-tenth (1/10) of one Share
  • Warrant call for redemption threshold: equals or exceeds $18.00 (cash or cashless exercise)
  • 100% held in trust ($10.00 per share)
  • 18 months to complete an acquisition + 4 month extension by vote (shareholders receive 1/2 warrant)
  • Underwriter fees: 2.0% + 3.5% business combination marketing agreement.  EarlyBirdCapital is sole book-runner.

Ellenoff Grossman & Schole LLP and Maples and Calder are Issuer’s Counsel and Underwriter’s Counsel, respectively.

 

Recent Posts
by Nicholas Alan Clayton on 2024-03-27 at 11:38am

Bannix (NASDAQ:BNIX) has entered into a definitive agreement to combine with VisionWave Technologies for $30 million. The combined company is expected to trade on the Nasdaq once the deal is completed with an initial outside date of September 14. Transaction Overview Bannix has about $17 million in its trust after seeing 77.4% of its shares...

by Nicholas Alan Clayton on 2024-03-27 at 7:33am

At the SPAC of Dawn Much of the attention yesterday was on tracking the swings of the newly-completed Trump Media (NASDAQ:DJT) deal with the FT going as far to suggest it may “make SPACs great again.” Not all of the day’s data points were on the positive side of the ledger, however. IB Acquisition Corp....

by Nicholas Alan Clayton on 2024-03-26 at 1:52pm

News and Rumors SpaceNews: Boeing (NYSE:BA) has sued Virgin Galactic (NASDAQ:SPCE) alleging the space tourism venture refused to pay $25 million it owed for design work and violated Boeing’s intellectual property rights. Virgin Galactic combined with Social Capital Hedosophia in 2019. Bloomberg: The most popular options contract for Trump Media (NASDAQ:DJT) predicts it to plunge...

by Nicholas Alan Clayton on 2024-03-26 at 11:51am

APx (NASDAQ:APXI) has entered into a definitive agreement to combine with precision medicine firms OmnigenicsAI and MultiplAI at an enterprise value $340 million. Once combined, these companies will offer DNA tests to consumers linked to predictive insights on their nutritional and genomic health. The combined company is expected to trade on the Nasdaq under the...

by Nicholas Alan Clayton on 2024-03-26 at 7:45am

At the SPAC of Dawn With the pricing of IB Acquisition Corp. (NASDAQ:IBACU), March now officially has two SPAC IPOs in the books but we”ll have to see if three price to match February’s numbers. The move brings 2024’s total count to six SPAC IPOs, which continues to be a slower pace than 2023, which turned...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved